Avalyn Pharma (AVLN) vs Janux Therapeutics (JANX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Avalyn Pharma is the larger company by market cap ($1.13 billion vs $1.10 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | JANX |
|---|---|---|
| Share price | $25.53 | $17.92 |
| Market cap | $1.13B | $1.10B |
| 1-day change | +0.39% | +6.73% |
| YTD return | — | +29.86% |
| 1-year return | — | -21.02% |
| 5-year return | — | -15.19% |
| EPS (TTM) | $-2.47 | $-1.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.17 | $35.34 |
| 52-week low | $24.15 | $12.12 |
| Distance from 52-week high | -36.45% | -49.29% |
| Average volume | 238.20K | 839.02K |
| Shares outstanding | 44.33M | 61.14M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AVLN vs JANX FAQ
Which is bigger, Avalyn Pharma or Janux Therapeutics?
Avalyn Pharma (AVLN) is larger, with a market capitalization of $1.13B compared with $1.10B for Janux Therapeutics (JANX).
Are Avalyn Pharma and Janux Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.